Millennium Management LLC boosted its stake in Afya Limited (NASDAQ:AFYA - Free Report) by 45.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 291,164 shares of the company's stock after purchasing an additional 90,383 shares during the period. Millennium Management LLC owned about 0.31% of Afya worth $5,139,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Lifestyle Asset Management Inc. increased its stake in Afya by 26.9% in the 2nd quarter. Lifestyle Asset Management Inc. now owns 14,784 shares of the company's stock worth $261,000 after purchasing an additional 3,133 shares during the period. Dodge & Cox increased its stake in Afya by 7.0% in the 4th quarter. Dodge & Cox now owns 29,183 shares of the company's stock worth $640,000 after purchasing an additional 1,900 shares during the period. Cubist Systematic Strategies LLC increased its stake in Afya by 136.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company's stock worth $622,000 after purchasing an additional 20,370 shares during the period. Renaissance Technologies LLC increased its stake in Afya by 19.7% in the 2nd quarter. Renaissance Technologies LLC now owns 266,500 shares of the company's stock worth $4,704,000 after purchasing an additional 43,800 shares during the period. Finally, Marshall Wace LLP increased its stake in Afya by 41.8% in the 2nd quarter. Marshall Wace LLP now owns 336,985 shares of the company's stock worth $5,948,000 after purchasing an additional 99,416 shares during the period. 88.02% of the stock is owned by hedge funds and other institutional investors.
Afya Trading Up 1.6 %
Shares of AFYA traded up $0.25 during mid-day trading on Friday, hitting $16.27. 154,997 shares of the company's stock traded hands, compared to its average volume of 132,723. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.40. Afya Limited has a 1 year low of $14.64 and a 1 year high of $22.48. The firm has a market capitalization of $1.52 billion, a P/E ratio of 13.45, a PEG ratio of 0.45 and a beta of 0.92. The business's 50-day moving average price is $17.00 and its 200-day moving average price is $17.36.
Afya (NASDAQ:AFYA - Get Free Report) last released its quarterly earnings results on Thursday, August 15th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.06. Afya had a return on equity of 18.82% and a net margin of 18.12%. The company had revenue of $155.40 million for the quarter, compared to analyst estimates of $151.83 million. As a group, sell-side analysts forecast that Afya Limited will post 1.52 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of brokerages have commented on AFYA. Morgan Stanley decreased their price target on Afya from $21.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Friday, June 21st. UBS Group initiated coverage on Afya in a research note on Friday, August 30th. They set a "neutral" rating and a $19.50 target price on the stock.
Check Out Our Latest Stock Analysis on AFYA
Afya Company Profile
(
Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
See Also
Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.